Drug Trial Radar · NCT07932613
Effect of Metaxalone 640 mg (M640) on Driving, Cognition, and EEG Dynamics Compared to Tizanidine 8 mg in Adults
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Dec 15, 2026
Primary completion
Jul 15, 2027
Study completion Oct 15, 2027
Sponsor
- Lead sponsor
- Primus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Participant takes a single pill after eating, takes a driving test on a simulator, takes thought and concentration computerized tests
Conditions
- Healthy Participant
Interventions
Metaxalone PillDrug
micronized metaxalone 640 mg pill
tizanidine 8 mgDrug
muscle relaxer for spasms
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Tmax in Standard Deviation of Lateral Position as evaluated by Driving Simulation SoftwareTime frame: Baseline dose to time of maximum concentration (Tmax), metaxalone 4 hours and tizanidine 1.5 hours post dose
- Change from Baseline to Tmax in Cognition as assessed by Creyos Cognitive Testing (CCT).Time frame: Baseline dose to time of maximum concentration (Tmax), metaxalone 4 hours and tizanidine 1.5 hours post dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Perseverance Research Center, LLC
Scottsdale, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.